"Atacand Plus" monotherapy effective for new hypertensive patients.
Published: 2007-03-16 06:58:00
Updated: 2007-03-16 06:58:00
A study for 5,543 patients with high blood pressure in 5 major cities including Seoul, Busan, Daegu, Daejeon and Guangju who visited to private clinics reported that Atacand Plus, a combination anti-hypertension drug of an angiotensin receptor blocker and diuretics, showed an excellent hypotensiv...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.